Kbc Group Nv Sangamo Therapeutics, Inc Transaction History

Kbc Group Nv

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$7.29 - $10.97 $82,377 - $123,961	-11,300 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$10.17 - $12.64 $91,530 - $113,760	9,000 Added 391.3%	11,300 $135,000
Q4 2019 Feb 11, 2020	BUY	$8.03 - $11.7 $17,103 - $24,921	2,130 Added 1252.94%	2,300 $19,000
Q3 2019 Nov 07, 2019	SELL	$9.05 - $12.22 $10,226 - $13,808	-1,130 Reduced 86.92%	170 $1,000
Q2 2019 Dec 03, 2019	BUY	$8.75 - $13.03 $11,375 - $16,939	1,300 New	1,300 $14,000
Q2 2019 Jul 30, 2019	SELL	$8.75 - $13.03 $11,375 - $16,939	-1,300 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$7.72 - $12.81 $10,036 - $16,653	1,300 New	1,300 $12,000
Q1 2019 May 10, 2019	SELL	$7.72 - $12.81 $6,562 - $10,888	-850 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$9.51 - $16.6 $8,083 - $14,110	850 New	850 $10,000
Q4 2018 Jan 31, 2019	SELL	$9.51 - $16.6 $8,083 - $14,110	-850 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$13.05 - $19.05 $11,092 - $16,192	850 New	850 $14,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $11,092 - $16,192	-850 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$13.9 - $19.8 $11,815 - $16,830	850 New	850 $12,000
Q2 2018 Aug 03, 2018	SELL	$13.9 - $19.8 $6,255 - $8,910	-450 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$16.7 - $26.35 $7,515 - $11,857	450 New	450 $9,000
Q1 2018 May 09, 2018	SELL	$16.7 - $26.35 $7,515 - $11,857	-450 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$11.6 - $17.35 $5,220 - $7,807	450	450 $7,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $387M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.